Open access
May 2026
Discovery and functional characterization of novel programmed death-ligand 1 monoclonal antibodies
Only one monoclonal antibody was identified as a potential therapeutic drug candidate thanks to its high capacity for checkpoint blockade and affinity, as well as its unique sequence specificity, comparable to those of anti-PD-L1 antibodies currently used in clinical practice.
Nurşah Ersezen, Maide Şeker, Arzu Aysan et al.
· Turkish journal of biology =... · 0 citations